Search

Director of UCL Advances and Director of UCL Enterprise Operations, Timothy Barnes, has won the Queen’s Award for Enterprise Promotion.

In the framework of the EU-project Solarjet, scientists demonstrate for the first time the entire production path to liquid hydrocarbon fuels from water, CO2 and solar energy. The key technological component is a solar reactor developed at ETH Zurich.

The structure of sodium channels – which play an essential role in the functioning of heart and nerve cells – are different than previously believed. Researchers hope their discovery will lead to improvements in drugs that act on the sodium channel to treat a range of cardiac and pain conditions.

KTH researchers are helping robots learn to cooperate, a difficult but potentially revolutionary challenge.

The Tech all stars competition offers the opportunity to pitch to successful entrepreneurs

Georgios Stavropoulos, a physicist in Greece’s Institute of Nuclear and Particle Physics, is pitching for his frontier deep sea neutrino project to be included under the EU’s new experimental regional funding scheme

Germany’s ambitious Energiewende made it the world’s largest energy lab. But with CO2 emissions up and electricity prices rising, the programme’s value as a blueprint for others is limited, says Stephan Reimelt, president and CEO of GE Energy, Germany.

Science|Business begins a series of viewpoints on the ethical dimensions of Europe’s biggest R&D programme

A new nano-membrane made out of the “super material” graphene is extremely light and breathable. Not only can this open the door to a new generation of functional waterproof clothing, but also to ultra-rapid filtration. The membrane produced by the researchers at ETH Zurich is as thin as is technologically possible.

Thermal power plants amounts to nearly 70% of all generated electricity worldwide, but also accounts for about one third of the global carbon dioxide emissions. By finding improved high temperature materials, thermal power plants can run more effectively to a lower cost, both economically and environmentally.

Imperial Innovations' portfolio company, Oxford Immunotec Global PLC (NASDAQ: OXFD), has received a Queen’s Award for Enterprise – the UK’s highest accolade in business success.

King's has been awarded funding as part of a £500 million investment in Centres for Doctoral Training (CDTs), by EPSRC, to support a new centre in the area of non-equilibrium systems: CANES.

With the Eurostars’ funding pot replenished by nearly €1.2B, EUREKA chairwoman Kristin Danielsen shares her thoughts on its importance for small businesses in Europe

Next generation of public-public research programmes in fields of clinical trials, SME financing, active ageing and metrology among initiatives that received green light from MEPs

Institutional issues and a lack of system thinking are hampering progress toward resolving Europe’s renewable energy dilemma, says Mark O’Malley, professor of electrical engineering at University College Dublin. More comprehensive and objective analysis would help.

As resistance to traditional antibiotics reaches crisis levels, scientists are poised to forage in hard-to-reach sea trenches for new antimicrobials and novel compounds that could provide the basis of new drugs

A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.

With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.